row semaglutide Drugmakers battle pharmacies over compounded Ozempic and Zepbound : Shots A proposal seeks to remove

Keystone Symposium, Keystone, CO February 22 (2016)

In February 2026, HHS announced plans to reclassify approximately 14 peptides including BPC-157 back to Category 1, with a formal Pharmacy Compounding Advisory Committee review scheduled for July 2026

These include things like behavioral health and nutritional counseling, lifestyle management programs that offer clinically proven support for weight management, nutrition, and stress relief, reimbursements for fitness center fees, and bariatric surgery for members with health risks from being obese."

These acts of self-regulation can be seen as an attempt by patients to achieve a personal balance between efficacy and negative effects

Active clinical trials are still important